ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 29 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,516 | -27.5% | 58,041 | -27.5% | 0.02% | -25.9% |
| Q2 2023 | $109,656 | -14.8% | 80,041 | +46.8% | 0.03% | -18.2% |
| Q1 2023 | $128,710 | +3.5% | 54,538 | 0.0% | 0.03% | -2.9% |
| Q4 2022 | $124,347 | -17.7% | 54,538 | 0.0% | 0.03% | -19.0% |
| Q3 2022 | $151,000 | +13.5% | 54,538 | 0.0% | 0.04% | +23.5% |
| Q2 2022 | $133,000 | -38.1% | 54,538 | 0.0% | 0.03% | -33.3% |
| Q1 2022 | $215,000 | -0.5% | 54,538 | 0.0% | 0.05% | 0.0% |
| Q4 2021 | $216,000 | – | 54,538 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $8,280,000 | 0.60% |
| CM Management, LLC | 75,000 | $464,000 | 0.35% |
| BVF INC/IL | 1,363,435 | $8,426,000 | 0.33% |
| Cormorant Asset Management, LP | 1,305,095 | $8,065,000 | 0.33% |
| Ikarian Capital, LLC | 344,578 | $2,129,000 | 0.15% |
| Woodline Partners LP | 781,376 | $4,829,000 | 0.08% |
| Eversept Partners, LP | 114,008 | $704,569 | 0.05% |
| INGALLS & SNYDER LLC | 51,149 | $316,000 | 0.01% |
| Virtu Financial LLC | 18,610 | $115,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 34,630 | $214,000 | 0.01% |